Uncovering the Harms of Treating Clostridioides difficile Colonization.

Loading...
Thumbnail Image

Date

2021-01-13

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

48
views
27
downloads

Citation Stats

Abstract

Patients with toxin-negative Clostridioides difficile-positive diarrhea are often treated with oral vancomycin with the assumption that treatment is more beneficial than harmful. However, this hypothesis has never been formally tested, and recent studies suggest that most such patients recover quickly without treatment and can be colonized rather than infected. Fishbein et al. conducted a prospective, placebo-controlled randomized trial to systematically evaluate the effects, risks, and benefits of oral vancomycin in these patients (S. R. S. Fishbein, T. Hink, K. A. Reske, C. Cass, et al., mSphere 6:e00936-20, 2020, https://doi.org/10.1128/mSphere.00936-20). Although small, the results are intriguing and suggest the adverse antibiotic-induced effects of vancomycin outweigh the clinical benefit when colonization is more likely than disease.

Department

Description

Provenance

Citation

Published Version (Please cite this version)

10.1128/msphere.01296-20

Publication Info

Polage, Christopher R, and Nicholas A Turner (2021). Uncovering the Harms of Treating Clostridioides difficile Colonization. mSphere, 6(1). pp. 1–3. 10.1128/msphere.01296-20 Retrieved from https://hdl.handle.net/10161/22414.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Polage

Christopher Robert Polage

Adjunct Associate Professor in the Department of Pathology
Turner

Nicholas Turner

Assistant Professor of Medicine

Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.